Importantly, IHC analyses of human glioblastoma with anti‐PKM2 pS222 antibody suggest that PKM2 pS222 levels have the strong correlation with the malignancy and prognosis of human glioblastoma, highlighting the prognostic potential of PKM2 pS222 levels for glioblastoma. Here, PKM is linked to glioblastoma.